We improve patient lives by unlocking the tissue phenome. In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer. Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com.
| Website | http://www.definiens.com |
| Revenue | $44.6 million |
| Funding | $20.4 million |
| Employees | 17 (10 on RocketReach) |
| Founded | 1994 |
| Address | Bernhard-Wicki-Strasse 5, Munich, Bavaria 80636, DE |
| Phone | +49 89 2311800 |
| Fax | +49 89 23118090 |
| Technologies |
JavaScript
,
HTML
,
PHP
+70 more
(view full list)
|
| Industry | Software, Data Mining, Biotechnology Research, Analytics, Biomedical Image Analysis Software, Software Development & Design, Data and Analytics, Drug Discovery and Development, Digital Pathology, Information Technology, Translational Research, Health Care, Tissue Diagnostics, Health Diagnostics, Companion Diagnostics, Image Recognition, Oncology, Automated Image Analysis, Tissue-based Biomarkers, Clinical Trials, Clinical Diagnostics |
| Keywords | Cell Analysis, Tissue Analysis, Therapeutic Strategies, Digital Pathology, Immune System, Image Analysis, Biomedical Imaging, Oncology, Immuno-Oncology, Cancer Research, Drug Discovery, Biomarker Discovery, Precision Medicine, Pharmaceutical Research, Medical Imaging, Healthcare It, Life Sciences, Biotechnology |
| Competitors | IBM, Lunit Global, Paige, PathAI, Proscia, HistoWiz, Aiforia Technologies, CureMetrix, INFINITT Healthcare, Zegami +40 more (view full list) |
| SIC | SIC Code 737 Companies, SIC Code 73 Companies |
| NAICS | NAICS Code 518 Companies, NAICS Code 51 Companies, NAICS Code 5182 Companies |
Looking for a particular Definiens, The Tissue Phenomics Company employee's phone or email?
Definiens, The Tissue Phenomics Company Questions
The Definiens, The Tissue Phenomics Company annual revenue was $44.6 million in 2026.
Ralf Huss is the Chief Medical Officer of Definiens, The Tissue Phenomics Company.
10 people are employed at Definiens, The Tissue Phenomics Company.
Definiens, The Tissue Phenomics Company is based in Munich, Bavaria.
The NAICS codes for Definiens, The Tissue Phenomics Company are [518, 51, 5182].
The SIC codes for Definiens, The Tissue Phenomics Company are [737, 73].
Top Definiens, The Tissue Phenomics Company Employees
-
11
-
Dirk Colditz
Director Quality Management at Definiens, The Tissue Phenomics Company
Halle (Saale), SA, DE1 -
Execmbm Rainer Gangnus
Senior Product Manager at Definiens, The Tissue Phenomics Company
Munich, Bavaria, Germany -
12
Related Companies
